PANE, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.849
NA - Nord America 1.580
EU - Europa 1.411
SA - Sud America 241
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.139
Nazione #
US - Stati Uniti d'America 1.516
SG - Singapore 776
RU - Federazione Russa 608
IT - Italia 388
VN - Vietnam 375
CN - Cina 371
BR - Brasile 186
HK - Hong Kong 148
DE - Germania 81
FR - Francia 66
NL - Olanda 64
GB - Regno Unito 45
FI - Finlandia 40
IN - India 35
CA - Canada 32
IE - Irlanda 28
BD - Bangladesh 25
JP - Giappone 24
MX - Messico 22
AR - Argentina 21
KR - Corea 20
EC - Ecuador 14
BG - Bulgaria 13
CI - Costa d'Avorio 12
SE - Svezia 12
ZA - Sudafrica 12
AT - Austria 11
IQ - Iraq 11
TR - Turchia 10
ES - Italia 9
PH - Filippine 9
UA - Ucraina 9
PL - Polonia 8
TW - Taiwan 8
CO - Colombia 7
KE - Kenya 7
MA - Marocco 7
CH - Svizzera 5
MK - Macedonia 5
TH - Thailandia 5
EG - Egitto 4
ET - Etiopia 4
ID - Indonesia 4
PK - Pakistan 4
VE - Venezuela 4
AL - Albania 3
BE - Belgio 3
CL - Cile 3
MY - Malesia 3
RO - Romania 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IR - Iran 2
LV - Lettonia 2
PY - Paraguay 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 5.139
Città #
Singapore 397
San Jose 313
Ashburn 158
Moscow 151
Chandler 143
Hong Kong 137
Beijing 104
Hefei 103
Ho Chi Minh City 95
Hanoi 79
Naples 60
Santa Clara 57
Amsterdam 44
The Dalles 43
Lauterbourg 33
Seattle 29
Los Angeles 28
Dallas 27
Millbury 26
Nanjing 25
New York 25
Munich 24
Buffalo 22
Da Nang 22
Milan 21
Tokyo 20
Council Bluffs 19
Dearborn 18
Des Moines 18
Seoul 18
Frankfurt am Main 17
Napoli 17
Boston 16
Haiphong 16
Princeton 16
Rome 16
São Paulo 16
Turku 16
Redondo Beach 14
Nola 13
Sofia 12
Bollate 11
Mexico City 11
Toronto 11
Lawrence 10
Norwalk 10
Orem 10
Biên Hòa 9
Dublin 9
Helsinki 9
Montreal 9
San Francisco 9
Can Tho 8
Cava De' Tirreni 8
Chicago 8
Houston 8
Shenyang 8
Stockholm 8
Denver 7
Gricignano di Aversa 7
Le Cannet 7
Poplar 7
Pune 7
Vienna 7
Warsaw 7
Wilmington 7
Atlanta 6
Baghdad 6
Bến Tre 6
Charlotte 6
Chennai 6
Curitiba 6
Johannesburg 6
London 6
Phoenix 6
Bexley 5
Brooklyn 5
Falkenstein 5
Giugliano in Campania 5
Jacksonville 5
Manchester 5
Monteforte Irpino 5
Mumbai 5
Nairobi 5
Nuremberg 5
Padova 5
Quito 5
Thái Nguyên 5
Tianjin 5
Turin 5
Washington 5
Afragola 4
Bangkok 4
Belo Horizonte 4
Bologna 4
Columbus 4
Dong Ket 4
Fairfield 4
Florence 4
Fortaleza 4
Totale 2.810
Nome #
GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response 213
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patients 192
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 170
The use of medical-grade cannabis in patients non-responders to Nabiximols 167
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 157
Prevalence and features of non-motor symptoms in Wilson's disease 157
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 156
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 154
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 152
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial 150
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 148
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 148
Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia 148
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 147
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 138
Peripheral markers of autophagy in polyglutamine diseases 138
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 136
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 134
Adult normative values for the PATA Rate Test 133
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 132
Mobitz type I and II atrioventricular blocks during fingolimod therapy 131
A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A 127
A randomized clinical trial of lithium in multiple system atrophy. 127
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 127
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 124
Efficacy of innovative therapies in myasthenia gravis: A systematic review, meta-analysis and network meta-analysis 121
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 121
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 120
The Multiple Faces of Spinocerebellar Ataxia type 2 120
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 116
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 116
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 110
Ataxia and Hypogonadism: a Review of the Associated Genes and Syndromes. 105
Fingolimod first dose safety in clinical practice. 105
Gradient of microstructural damage along the dentato‐thalamo‐cortical tract in Friedreich ataxia 104
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 100
Altered Intracerebellar Functional Connectivity in Friedreich's Ataxia: A Graph-Theory Functional MRI Study 86
Brain Structure and Degeneration Staging in Friedreich Ataxia: Magnetic Resonance Imaging Volumetrics from the ENIGMA-Ataxia Working Group 75
The use of medical grade cannabis in Italy for drug-resistant epilepsy: a case series 58
Nonvascular Parkinsonism in Fabry Disease: Results from Magnetic Resonance and Dopamine Transporter Imaging 47
null 23
Totale 5.233
Categoria #
all - tutte 15.378
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.378


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022188 3 6 1 1 5 10 6 5 31 13 37 70
2022/2023344 36 37 13 19 40 33 9 28 58 52 16 3
2023/2024256 7 33 17 21 14 25 13 55 7 2 32 30
2024/20251.367 51 31 9 30 63 63 163 94 95 121 528 119
2025/20262.753 251 276 307 271 463 123 322 150 272 177 118 23
Totale 5.233